NEW YORK] Novartis agreed to buy biotechnology company Avidity Biosciences in a deal that values it at US$12 billion, ...

Investors looking for stocks that can produce eye-popping gains in a short time frame often turn toward biotechnology stocks. In this wonky industry, encouraging results from a clinical trial can turn ...

Biotechnology is transforming natural health products. Advanced methods improve plant extract purity and potency. This ...

BIB ETF is best suited for high-risk, active investors in the accumulation phase or retirees managing portfolios hands-on.

MAIA Biotechnology (MAIA) announced highlights from a recent presentation at the European Society for Medical Oncology, ESMO, Congress 2025 held ...

Some genetic disorders—such as cystic fibrosis, hemophilia and Tay Sachs disease—involve many mutations in a person's genome, ...

The iShares Biotechnology ETF (IBB) provides exposure to healthcare innovation with a focus on the biggest firms by market ...

Microbial biotechnology is a dynamic field, The origins of microbiology can be traced back to the pioneering research by scientists such as Louis Pasteur and Robert Koch in the 19 th century. Within a ...

The 18,500-square-foot building offers industry-grade training for biotech technicians and is part of McCord's efforts to brand Generation Park as a premier life sciences hub in Houston.

Doha's healthcare expenditure is slated to touch $13bn by 2030, showing a 14% compound annual growth rate (CAGR) and ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...